欧洲及全球系统性红斑狼疮患者获得医疗服务的挑战与机遇
本文讨论了系统性红斑狼疮(SLE)患者在欧洲及全球获得医疗服务面临的挑战,包括患者与专科中心的地理距离远、风湿科医生稀缺导致诊断和管理延迟、初始症状非特异、部分新获批治疗在欧洲多国及中低收入国家不可及且医保覆盖不足。文章介绍了欧盟已实施的改善罕见复杂疾病就医的举措,如欧洲参考网络(ERNs)中的自身免疫病ReCONNET,以及Lupus Europe等患者组织在提高认识和倡导改善就医中的作用。
要点
- SLE患者与专科中心地理距离远及风湿科医生稀缺加剧诊断和管理延迟。
- SLE初始症状常非特异,为基层医疗人员和非专科医生提供指南极为重要。
- 多种近期获批的SLE治疗在欧洲多国及中低收入国家不可及,部分可及国家医保未覆盖。
核心结论
- 改善SLE患者健康结局需要全面理解患者疾病路径,多方协作可迈向所有狼疮患者获得全面及时照护的未来。
研究设计与样本
- 本文为PubMed收录的Rheumatology (Oxford)文章,原文未报告研究设计与样本。
主要发现
- 患者与专科中心的地理距离远及风湿科医生稀缺加剧SLE诊断和管理延迟。
- SLE初始症状常非特异,为基层医疗人员和非专科医生提供指南极为重要。
- 多种近期获批的SLE治疗在欧洲多国及许多中低收入国家不可及,在可及的中低收入国家也并非总被医保覆盖,使较低社会经济地位者几乎无法获得。
关键数值与推荐
- 欧盟已实施多项改善罕见复杂疾病(包括SLE)就医的规定,如欧洲参考网络(ERNs)中的自身免疫病ReCONNET。
- ReCONNET等ERNs是涉及欧洲各地医疗专业人员的虚拟网络,旨在改善需要高度专业化治疗和知识资源集中的罕见复杂疾病患者的照护。
- Lupus Europe等狼疮患者组织在提高SLE认识和倡导改善就医方面发挥关键作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SLE presents significant challenges for patients and health-care professionals (HCPs), both across Europe and worldwide. Improving health-care outcomes for patients with SLE requires a comprehensive understanding of patient disease pathways. In particular, the geographical distance between SLE patients and specialized care centres, combined with the scarcity of rheumatologists, exacerbates delays in diagnosis and management. Also, the initial SLE symptoms can often be non-specific, and providing guidelines for primary HCPs and other non-specialists is extremely important. Improvement in access to treatment is also important, with several recently approved therapies for SLE not being available in several European countries and many low- and middle-income countries (LMICs). Furthermore, in the LMICs in which these treatments are available, they are not always covered by the health-care system, making their access almost impossible for those of lower socio-economic status. A number of provisions are already in place within the European Union, to improve access to care for patients with rare and complex diseases, including those with SLE. In particular, European Reference Networks (ERNs), such the ERN for Autoimmune Diseases ReCONNET, are virtual networks involving HCPs across Europe with the aim of improving the care of patients with rare and complex diseases that require highly specialized treatment and a concentration of knowledge and resources. In addition, lupus patient organizations such as Lupus Europe play a crucial role in raising awareness of SLE and advocating for improved access to care. Together, we can work towards a future where all people living with lupus receive the comprehensive and timely care they deserve.
引用
- Mosca M, Bruce IN, Andersen J, et al. Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide. Rheumatology (Oxford). 2024. PMID: 38949781. doi:10.1093/rheumatology/keae227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。